A study on efficacy of combined Chinese and Western medicine and follow-up of long-term prognosis in patients with novel coronavirus pneumonia (COVID-19)
Not Applicable
Recruiting
- Conditions
- ovel Coronavirus Pneumonia (COVID-19)
- Registration Number
- ITMCTR2000004148
- Lead Sponsor
- Public Health Clinical Center of Chengdu
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- All
- Target Recruitment
- Not specified
Inclusion Criteria
Patients hospitalized in Xi'an eighth hospital due to covid-19 from January to December 2020:
1. Sign informed consent;
2. The patient was diagnosed as covid-19 during hospitalization and was discharged alive;
3. Complete clinical data during hospitalization.
Exclusion Criteria
Too old to move or take care of themselves, or who cannot get to the Public Health Clinical Center of Chengdu Hospital for examination.
Study & Design
- Study Type
- Observational study
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method blood glucose testing;echocardiography;Blood routine;liver and kidney function;nucleic acid tests;chest CT;
- Secondary Outcome Measures
Name Time Method
Related Research Topics
Explore scientific publications, clinical data analysis, treatment approaches, and expert-compiled information related to the mechanisms and outcomes of this trial. Click any topic for comprehensive research insights.
What molecular mechanisms underlie combined Chinese and Western medicine in treating SARS-CoV-2 viral replication and immune response modulation?
How does the efficacy of integrated traditional Chinese medicine compare to standard-of-care treatments for severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) pneumonia?
What biomarkers are associated with favorable long-term prognosis in patients receiving combined Chinese and Western medicine for novel coronavirus pneumonia?
What are the potential adverse events and management strategies for integrated traditional Chinese medicine in SARS-CoV-2 treatment regimens?
What combination approaches or alternative therapies are being explored for SARS-CoV-2 pneumonia in observational studies sponsored by Public Health Clinical Center of Chengdu?